AbbVie
ABBV
#29
Rank
ยฃ369.17 B
Marketcap
ยฃ208.91
Share price
1.49%
Change (1 day)
20.87%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of June 2026 : ยฃ53.51 Billion

According to AbbVie's latest financial reports the company's total debt is ยฃ53.51 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ50.11 B-6.33%
2024-12-31ยฃ53.50 B14.79%
2023-12-31ยฃ46.61 B-10.87%
2022-12-31ยฃ52.29 B-7.94%
2021-12-31ยฃ56.80 B-10.02%
2020-12-31ยฃ63.13 B24.07%
2019-12-31ยฃ50.88 B60.24%
2018-12-31ยฃ31.75 B14.85%
2017-12-31ยฃ27.64 B-7.4%
2016-12-31ยฃ29.85 B39.71%
2015-12-31ยฃ21.37 B122.16%
2014-12-31ยฃ9.61 B7.78%
2013-12-31ยฃ8.92 B-7.95%
2012-12-31ยฃ9.69 B31297.55%
2011-12-31ยฃ30.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ47.75 B-10.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ41.49 B-22.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ43.30 B-19.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ6.31 B-88.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ19.83 B-62.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ34.04 B-36.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ24.36 B-54.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ18.26 B-65.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.30 B-99.43%๐Ÿ‡บ๐Ÿ‡ธ USA